Scholars Central

EditorialPublished 2012

Treatment for Congenital Cytomegalovirus Infection: who, for how long,with what Drug Regimen?

Authors: Bernhard Resch

Journal of Neonatal Biology

Volume 1 · Issue 2 · Pages 1–3

Ask about this article

Abstract

Select any words in the title or abstract, or press this and choose a sentence.

Congenital cytomegalovirus (CMV) infection is the most frequently identified viral cause of mental retardation and is the leading non-genetic cause of neurosensory hearing loss in developed countries, and is the most common congenital infection in human beings, with approximately 1% of all infants born alive in the United States being infected with CMV Infants with symptomatic CMV infection with observations at birth including petechiae, hepatosplenomegaly, microcephaly, thrombocytopenia, or jaundice with conjugated hyperbilirubinemia showed in 70% of cases abnormal computed tomographic (CT) scans with intracerebral calcification being the most frequent finding, and again 90% of the children with an abnormal newborn CT scan developed at least one sequela [4]. In addition, almost half of the children with CT abnormalities had an IQ <50 compared with none of those with a normal CT. Of infected fetuses, approximately 10% are symptomatic at birth, and 90% of symptomatic survivors have significant neurologic sequelae, including hearing deficits in 30% to 65%

Ask about this article

Answers come only from this article's title, abstract and keywords, each sentence pointing to where it comes from. Your question is sent to OpenAI to write the answer. Scholars Central does not store it.

Try:

Conferences in this field

Upcoming conferences in this field.

Follow

New articles from what you follow go into your email digest, once you agree to alert emails.

  • JournalJournal of Neonatal Biology
  • SubjectPaediatrics & Neonatology
  • BylineArticles whose byline prints “Bernhard Resch”